Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies
Alexandria May, PharmD, BCPS
Chandrikha Chandrasekharan, MBBS
Decoding epNECs: Diagnostic Challenges and Emerging Strategies
Brian P. McDonough, MD, FAAFP
Andrew E. Hendifar, MD
DESTINY-Breast05 Findings Lead to New Indication for Trastuzumab Deruxtecan as Adjuvant Treatment for Residual Invasive Disease
Sara A. Hurvitz, MD, FACP
DESTINY-Breast11: Trastuzumab Deruxtecan Followed by THP Yields New Indication in the Neoadjuvant Setting.
Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
Charles Turck, PharmD, BCPS, BCCCP
Rohit Thummalapalli, MD
Navigating Classification of High-Grade Neuroendocrine Neoplasms
Key Differences in Pulmonary and Extrapulmonary NEC Management
Lowell B. Anthony, MD, FACP
Optimizing Treatment Intensity in Early-Stage TNBC
Roberto Leon-Ferre, MD
Matching TNBC Treatment Intensity to Patient Needs
Talking Through Treatment: Patient–Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
Jennifer Johnson, MD, PhD
Adam J. Luginbuhl, MD
Implementing Lifestyle Medicine in Breast Cancer Survivorship Care
Amy Comander, MD
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
Jacob Sands, MD
Jia Luo, MD
Partnering Through Treatment: Preparing for Immunotherapy in the Perioperative Setting
Turning Evidence Into Action: Applying Perioperative Data to Real-World Practice
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
Reducing the Rise of Uterine Cancer in the United States
Richard T. Penson, MD, MRCP
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.